Cargando…
Lower Respiratory Tract Infection: An Unrecognised Risk Factor for High Altitude Pulmonary Oedema?
The case of a 25-year-old expedition doctor who developed high altitude pulmonary oedema (HAPE) while climbing in the Swiss Alps is presented, with reference to the literature. The patient’s symptoms of HAPE were typical. Less typical was the fact that the doctor had previously been to similar altit...
Autor principal: | Humphries, Christopher P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346869/ https://www.ncbi.nlm.nih.gov/pubmed/30755928 http://dx.doi.org/10.12890/2017_000539 |
Ejemplares similares
-
Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension
por: Wang, Tingting, et al.
Publicado: (2020) -
High-altitude pulmonary oedema: Newer treatment modalities for an age-old problem
por: Yanamandra, Uday, et al.
Publicado: (2019) -
Unrecognised Insanity
Publicado: (1861) -
Oral prednisolone for acute lower respiratory tract infection in clinically unrecognised asthma: an exploratory analysis of the Oral Steroids for Acute Cough (OSAC) randomised controlled trial
por: Hawkey, Sean, et al.
Publicado: (2020) -
Deregulated hypoxic response in myeloid cells: A model for high‐altitude pulmonary oedema (HAPE)
por: Gojkovic, Milos, et al.
Publicado: (2020)